A carregar...
Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)
Objective: To assess long-term outcomes for effectiveness, safety, and treatment burden after injection of 0.2 µg/day fluocinolone acetonide [FAc] intravitreal implant (ILUVIEN(®)) in patients with persistent or recurrent diabetic macular edema (DME) and 6–18 months of follow-up. Methods: Retrospect...
Na minha lista:
| Publicado no: | Int Med Case Rep J |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6489583/ https://ncbi.nlm.nih.gov/pubmed/31114396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S191171 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|